The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress

Acta Histochemica

Volumn 111, Issue 2, 2009, Pages 112-118

  Çikler, Esra ^a   Ersoy, Yasemin ^a   Çetinel, Şule ^a   Ercan, Feriha ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Degranulation; Mast cells; Montelukast; Water avoidance stress

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; AVOIDANCE BEHAVIOR; CELL COUNT; CONTROLLED STUDY; DERMIS; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MAST CELL DEGRANULATION; NONHUMAN; PSORIASIS; RAT; SKIN; SKIN DISEASE; STRESS;

ACETATES; ANIMALS; CELL DEGRANULATION; DERMIS; FEMALE; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; LEUKOTRIENE ANTAGONISTS; MAST CELLS; QUINOLINES; RATS; RATS, WISTAR; STRESS, PHYSIOLOGICAL; TOLONIUM CHLORIDE; TRYPTASES;

ANIMALIA; RATTUS;

EID: 61349188412     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2008.04.006     Document Type: Article

References (40)

1. Bennett E.J., Tennant C.C., Piesse C., Badrock J., and Kellow J. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 43 (1998) 256-261
2. Bouchelouche K., Kristensen B., Nordling J., Horn T., and Bouchelouche P. Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis. J Urol 166 6 (2001) 2121-2125
3. 2+ elevation and contraction of the human detrusor muscle. J Urol 170 2 Pt 1 (2003) 638-644
4. Bugajski A.J., Chiap Z., Gadek-Michalska A., and Bugajski J. Effect of isolation stress on brain mast cells and brain histamine levels in rats. Agents Actions 41 (1994) 75-76
5. Chen Z., Irani A.A., Bradford T.R., Craig S.S., Newlands G., Miuer H., et al. Localization of rat tryptase to a subset of the connective tissue type of mast cell. J Histochem Cytochem 41 7 (1993) 961-969
6. Chrousos G.P., and Gold P.W. The concepts of stress system disorders: overview of behavioral and physical homeostasis. JAMA 267 (1992) 1244-1252
7. Cikler E., Ercan F., Cetinel S., Contuk G., and Sener G. The protective effects of melatonin against water avoidance stress-induced mast cell degranulation in dermis. Acta Histochem 106 6 (2005) 467-475
8. Collins S.M., McHugh K., Jacobson K., Khan I., Riddell R., Murase K., et al. Previous inflammation alters the response of the rat colon to stress. Gastroenterology 111 (1996) 1509-1515
9. Ercan F., Oktay S., and Erin N. Role of afferent neurons in stress induced degenerative changes of the bladder. J Urol 165 1 (2001) 235-239
10. Ersoy Y., Cikler E., Cetinel S., Sener G., and Ercan F. Leukotriene D4 receptor antagonist montelukast alleviates water avoidance stress-induced degeneration of the gastrointestinal mucosa. Prostaglandins, Leukotrienes and Essential Fatty Acids 78 (2008) 189-197
11. Farber E.M., Nickoloff B.J., Recht B., and Fraki J.E. Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am Acad Dermatol 14 (1986) 305-311
12. Figueroa D.J., Borish L., Baramki D., Philip G., Austin C.P., and Evans J.F. Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy 33 (2003) 1380-1388
13. Finsnes F., Lyberg T., Christensen G., and Skjonsberg O.H. Leukotriene antagonism reduces the generation of endothelin-1 and interferon-gamma and inhibits eosinophilic airway inflammation. Respir Med 96 (2002) 901-906
14. Holma R., Salmenpera P., Riutta A., Virtanen I., Korpela R., and Vapaatalo H. Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats. Eur J Pharmacol 429 (2001) 309-318
15. Huston D.P., and Bressler R.B. Urticaria and angioedema. Med Clin Nourth Am 76 (1992) 805-840
16. Ihaku D., Cameron L., Suzuki M., Molet S., Martin J., and Hamid Q. Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5-expressing cells in Brown Norway rats. J Allergy Clin Immnol 104 (1999) 1147-1154
17. Kanaoka Y., and Boyce J.A. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol 173 (2004) 1503-1510
18. MacQueen G., Marshall J., Perdue M., Siegel S., and Bienenstock J. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease, II. Science 243 (1989) 83-85
19. Mellor E.A., Austen K.F., and Boyce J.A. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med 195 (2002) 583-592
20. Mihm M.C., Soter N.A., Dvorak H.F., and Austen K.F. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67 (1976) 305-311
21. Ozdamar S.O., Seckin D., Kandemir B., and Turanli A.Y. Mast cells in psoriasis. Dermatology 192 (1996) 189-190
22. Russell M., Dark K.A., Cummins R.W., Ellman G., Callaway E., and Peeke H.V. Learned histamine release. Science 225 (1984) 733-734
23. Santos J., Benjamin M., Yang P.C., Prior T., and Perdue M.H. Chronic stress impairs rat growth and jejunal epithelial barrier function: role of mast cells. Am J Physiol Gastrointest Liver Physiol 278 (2000) 847-854
24. Selbekk B.H., Flaten O., and Hanssen L.E. The in vitro effect of neurotensin on human jejunal mast cells. Scand J Gastroenterol 15 (1980) 457-460
25. Sener G., Kapucu C., Çetinel S., Çikler E., and Ayanoglu-Dülger G. Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa. Prostaglandins Leukot Essent Fatty Acids 72 (2005) 1-11
26. Sener G., Kabasakal L., Çetinel S., Contuk G., Gedik N., and Yegen B. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns 31 (2005) 587-596
27. Shiota N., Shimoura K., and Okunishi H. Pathophysiological role of mast cells in collagen-induced arthritis: study with a cysteinyl leukotriene receptor antagonist, montelukast. Eur J Pharmacol 548 (2006) 158-166
28. Singh L.K., Pang X., Alexacos N., Letourneau R., and Theoharides T.C. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: a link to neurogenic skin disorders. Brain Behav Immun 13 (1999) 225-239
29. Sjostrom M., Jakobsson P.J., Juremalm M., Ahmed A., Nilsson G., Macchia L., et al. Human mast cells express two leukotriene C4 synthase isoenzymes and the CysLT1 receptor. Biochim Biophys Acta 1583 (2002) 52-53
30. Soderholm J.D., Yang P.C., Ceponis P., Vohra A., Riddell R., Sherman P.M., et al. Chronic stress induced mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology 123 (2002) 1008-1099
31. Sugiura H., and Uehara M. Mitosis of mast cells in skin lesions of atopic dermatitis. Acta Derm Venereol 73 (1993) 296-299
32. Theoharides T.C., Spanos C.P., Pang X., Alferes L., Ligris K., Letourneau R., et al. Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology 136 (1995) 5745-5750
33. Theoharides T.C., Singh L.K., Boucher W., Pang X., Letourneau R., Webster E., et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139 (1998) 403-413
34. Theoharides T.C., and Cochrane D.E. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 46 (2004) 1-12
35. Theoharides T.C., and Sant G.R. The role of the mast cell in interstitial cystitis. Urol Clin North Am 21 (1994) 41-43
36. Tugtepe H., Sener G., Velioglu-Ogünç A., Çetinel S., Gedik N., and Yegen B.C. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1. Eur J Pharmacol 557 1 (2007) 65-69
37. Wallace J.L., Beck P.L., and Morris G.P. Is there a role for leukotrienes as mediators of ethanol-induced gastric mucosal damage?. Am J Physiol 254 (1988) 117-123
38. Wallace J.L., MacNaughton W.K., Morris G.P., and Beck P.L. Inhibition of leukotriene synthesis markedly accelaretes healing in rat model of inflammatory bowel dieases. Gastroenterology 96 (1989) 29-36
39. Weston A.P., Biddle W.L., Bhatia P.S., and Miner P.B. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 38 (1993) 1590-1595
40. Yanase D.J., and David-Bajar K. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis. Am Acad Dermatol 44 1 (2001) 83-89